Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease

被引:43
作者
Maia, Serge [2 ,3 ]
Arlicot, Nicolas [2 ,3 ]
Vierron, Emilie [2 ]
Bodard, Sylvie [2 ]
Vergote, Jackie [2 ]
Guilloteau, Denis [2 ,3 ]
Chalon, Sylvie [1 ,2 ,3 ]
机构
[1] INSERM, UFR Sci Pharmaceut, UMR, U930, F-37200 Tours, France
[2] Univ Tours, F-37000 Tours, France
[3] CHRU, F-37000 Tours, France
关键词
6-hydroxydopamine; microglia; SPECT; TSPO (18 kDa); PROTEIN; 18; KDA; BENZODIAZEPINE BINDING-SITES; MICROGLIAL ACTIVATION; SUBSTANTIA-NIGRA; PHARMACOLOGICAL CHARACTERIZATION; INTRASTRIATAL; 6-HYDROXYDOPAMINE; DOPAMINE TRANSPORTER; PARTIAL LESION; TIME-COURSE; DA RELEASE;
D O I
10.1002/syn.21543
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
As neuroinflammatory processes are involved in the pathogenesis of Parkinson's disease (PD), we achieved the longitudinal evaluation of them in parallel with the modifications of dopaminergic function at several time-points after 6-hydroxydopamine (6-OHDA) lesion in the rat mimicking an early stage of PD. After unilateral intrastriatal 6-OHDA administration, we quantified the temporal evolution of the 18 kDa translocator protein (TSPO), TH-immunoreactivity and dopamine transporters in the striatum and substantia nigra pars compacta (SNc) from 3- to 56-days postlesion (dpl). Increased binding of TSPO ligands used, i.e., [3H]PK11195 and [125I]CLINDE, was observed in the lesioned striatum at 3, 7, and 14 dpl, followed by a progressive return to the basal level at 56 dpl. The binding profile in the SNc showed progressive binding beginning at 3 dpl, peaking at 14 dpl, and progressively decreasing until 56 dpl. In this model, the neuroinflammatory and neurodegenerative processes occurred concomitantly. The transitory occurrence of microglial activation could be involved in the lasting installation of dopaminergic neuron loss. Synapse, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:573 / 583
页数:11
相关论文
共 45 条
[1]  
[Anonymous], 2011, R: A Language and Environment for Statistical Computing
[2]   Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE [J].
Arlicot, Nicolas ;
Petit, Edwige ;
Katsifis, Andrew ;
Toutain, Jerome ;
Divoux, Didier ;
Bodard, Sylvie ;
Roussel, Simon ;
Guilloteau, Denis ;
Bernaudin, Myriam ;
Chalon, Sylvie .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) :2371-2380
[3]   Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation [J].
Arlicot, Nicolas ;
Katsifis, Andrew ;
Garreau, Lucette ;
Mattner, Filomena ;
Vergote, Jackie ;
Duval, Stephanie ;
Bodard, Sylvie ;
Guilloteau, Denis ;
Chalon, Sylvie .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (12) :2203-2211
[4]   [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? [J].
Bartels, A. L. ;
Willemsen, A. T. M. ;
Doorduin, J. ;
de Vries, E. F. J. ;
Dierckx, R. A. ;
Leenders, K. L. .
PARKINSONISM & RELATED DISORDERS, 2010, 16 (01) :57-59
[5]   LABELING OF PERIPHERAL-TYPE BENZODIAZEPINE BINDING-SITES IN THE RAT-BRAIN BY USING [PK-H-3 11195, AN ISOQUINOLINE CARBOXAMIDE DERIVATIVE - KINETIC-STUDIES AND AUTORADIOGRAPHIC LOCALIZATION [J].
BENAVIDES, J ;
QUARTERONET, D ;
IMBAULT, F ;
MALGOURIS, C ;
UZAN, A ;
RENAULT, C ;
DUBROEUCQ, MC ;
GUEREMY, C ;
LEFUR, G .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (06) :1744-1750
[6]   Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease [J].
Bjorklund, A ;
Rosenblad, C ;
Winkler, C ;
Kirik, D .
NEUROBIOLOGY OF DISEASE, 1997, 4 (3-4) :186-200
[7]   Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model [J].
Blandini, Fabio ;
Levandis, Giovanna ;
Bazzini, Eleonora ;
Nappi, Giuseppe ;
Armentero, Marie-Therese .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 25 (02) :397-405
[8]   Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J].
Blum, D ;
Torch, S ;
Lambeng, N ;
Nissou, MF ;
Benabid, AL ;
Sadoul, R ;
Verna, JM .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) :135-172
[9]   11C-DPA-713:: A novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation [J].
Boutin, Herve ;
Chauveau, Fabien ;
Thominiaux, Cyrille ;
Gregoire, Marie-Claude ;
James, Michelle L. ;
Trebossen, Regine ;
Hantraye, Philippe ;
Dolle, Frederic ;
Tavitian, Bertrand ;
Kassiou, Michael .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) :573-581
[10]   Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease [J].
Broom, Lauren ;
Marinova-Mutafchieva, Lilia ;
Sadeghian, Mona ;
Davis, John B. ;
Medhurst, Andrew D. ;
Dexter, David T. .
FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (05) :633-640